Page 3 - Jay Lecoque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up Wed, 3rd Mar 2021 20:16 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Cambria Automobiles PLC - franchised motor retailer - Says continued to be hurt by UK Covid-19 restrictions in five months to January 31. Welcomes reopening of car showrooms penned for April but warns will miss out on busiest month of trading in March. Says overall trading performance during five-month period improves amid Covid-19-related cost reductio...

19 February 2021 | 09:36am StockMarketWire.com - SourceBio said it has entered into an agreement with outsourcing specialist Mitie Security to manage the delivery of Covid-19 testing services as part of the Department of Health and Social Care’s pilot scheme. The company will also oversee all laboratory operations, clinical governance, quality assurance, staff training, sample processing and information management. Currently four mobile testing laboratories using Oxford Nanopore's LamPORE tests for Covid-19 have been deployed in the pilot. SourceBio will manage the mobile testing service o...

Expectations for “continued significant earnings growth” remain unchanged, investors were told

Almost fivefold increase in adjusted EBITDA and strong balance sheet position   SourceBio International plc (AIM: SBI), the international provider of integrated state of the art laboratory services and products, provides the following trading update for the year ended 31 December 2020.   The Company confirms that full year results will be in line with market expectations, recording considerable growth in both revenues and EBITDA year-on-year. The Company expects to report, subject to audit, revenues of approximately £50.7 million, compared to revenues of £21....

  SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. Group revenues are derived from four core businesses areas:   · Healthcare Diagnostics - histopathology and clinical diagnostic services for the NHS and private healthcare across the UK and Ireland. · Genomics - DNA sequencing services for pharmaceutical and biotechnology c...